Note: Ingredients listed on restricted chemical lists
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
≥90
EC/CAS
200-927-2
Name of the chemical
Trichloroacetic acid
Concentration
2 - 5
General Information
Version
1.1
Revision date
2022-07-29
Product name
Ponceau S Red solution
Product name
Ponceau S Red solution
Identification on the label/Trade name
Ponceau S Red solution GEN
1.2.1 Relevant identified uses
Laboratory use
Emergency telephone
+34 937 077 970, 0344 892 0111
Icons in SDS
Company Information
company name
labbox labware s.l
e-mail address of the competent person responsible for the Safety Data Sheet
info@labbox.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H314, H335, H410
Hazard statements
Code
Statements
H314
Causes severe skin burns and eye damage
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS09
Signal word
Danger
Contains
Ponceau S, C.I. 27195 ; Trichloroacetic acid 99%
Hazard statements
H314 - Causes severe skin burns and eye damage. H335 - May cause respiratory irritation. H410 - Very toxic to aquatic life with long lasting effects.
Precautionary statements
P273 - Avoid release to the environment. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P301+P330+P331 - IF SWALLOWED: rinse mouth. Do NOT induce vomiting. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P309+P311 - IF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
